Abstract
D.Phil.
The objective of the research described in the first part of this thesis was to develop a general method utilising palladium catalysed reactions for the synthesis of the anti-cancer compound, lavendamycin and analogs thereof. Therefore, the development of a general route to synthetic euivalents of the lavendamycin AB quinoline system, 2-hydroxyquinolines, with potential for coupling to the CDE or CD moiety, was addressed. The first protocol for the synthesis of 2-hydroxyquinolines invloved to the use of appropriately substituted o-nitrophenyltriflates (readily prepared from phenols) in a Heck reaction under neutral conditions followed by a one-pot reduction and cyclisation step. The synthetic potential of such an approach was demonstrated by the preparation of a suitable lavendamycin AB synthon from commecially avalaible guiacol. A second general strategy towards the synthesis of the AB synthon utilising a performed ring system commecially available 8-hydroxyquinoline has been successfully developed. This approach requiring the introduction of a suitable leaving group in the 2-position involved the following sequence of reactions: protection of 8-hydroxyl group N-oxidation, and a rearrangement step. This methodology yielded five different key intermediates all possessing suitable functionality in the 2 position which would allow further cross-coupling to an appropriate CDE ring equivalent.